Table 1.
Subject | HIV status | Infection duration | CD4 T cells per μl blood | pVL | BAL VL | BAL % lymphs |
---|---|---|---|---|---|---|
1430 | Chronic | 3 years | 827 | 1,020 | ND | ND |
1435 | Acute | < 1 month | 410 | >100,000 | ND | ND |
1437 | Chronic | 8 years | 218 | 6,940 | ND | ND |
1438 | AIDS | >10 years | 147 | 4,960 | ND | ND |
1445 | Early | 1 year | 271 | 32,600 | ND | ND |
1449 | Acute | < 1 month | 333 | >100,000 | ND | ND |
1455 | Early | 1 year | 209 | 7,210 | ND | ND |
1456 | Chronic | 4 years | 478 | 174,000 | ND | ND |
1458 | Early | 1 year | 400 | 439,000 | ND | ND |
1462 ● | AIDS | 14 years | 81 | 35,000 | ND | ND |
1463 ○ | Early | 1 year | 259 | 27,200 | ND | ND |
1464 | Chronic | 15 years | 202 | 122,000 | ND | ND |
1479 | Chronic | 5 years | 273 | 1,650 | ND | ND |
1292 | HIV− | NA | ND | 0 | ND | ND |
1420 | HIV− | NA | ND | 0 | ND | ND |
1421 | HIV− | NA | ND | 0 | ND | ND |
1423 | HIV− | NA | ND | 0 | ND | ND |
1424 | HIV− | NA | ND | 0 | ND | ND |
1425 | HIV− | NA | ND | 0 | ND | ND |
99 | AIDS | >1 year | 184 | 31,900 | ND | 20 |
98 ▪ | Chronic | >5 years | 218 | 23,000 | ND | ND |
100 | Early | 6 month | 464 | 21,000 | < 50 | 12 |
101 | Chronic | 4 years | 425 | 140,000 | 2030 | 49 |
107 | Chronic | >5 years | 624 | 2,380 | < 50 | 9 |
114 □ | Chronic | < 5 years | 416 | 8,100 | < 50 | 2 |
115 | Chronic | >10 years | 361 | 55,300 | < 50 | 13 |
119 | Chronic | Unknown | 354 | 3,200 | ND | 3 |
120 | Chronic | 19 years | 471 | 13,000 | < 50 | 2 |
127 | AIDS | 10 years | 121 | 2,210 | ND | 9 |
128 | AIDS | >1 year | 37 | 85,000 | ND | 20 |
129 | AIDS | >4 years | 92 | 99,800 | < 50 | 15 |
130 | AIDS | >1 year | 48 | >750,000 | 221 | 16 |
93 | HIV− | NA | ND | 0 | 0 | 49 |
95 | HIV− | NA | ND | 0 | 0 | 22 |
116 | HIV− | NA | ND | 0 | 0 | 3 |
118 | HIV− | NA | ND | 0 | 0 | 21 |
121 | HIV− | NA | ND | 0 | 0 | 1 |
129 | HIV− | NA | ND | 0 | 0 | 10 |
BAL, bronchoalveolar lavage; pVL, plasma viral load; NA, not applicable; ND, not determined.